Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19

Detalles Bibliográficos
Autores principales: Tendilla-Beltrán, Hiram, Flores, Gonzalo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141345/
https://www.ncbi.nlm.nih.gov/pubmed/34045093
http://dx.doi.org/10.1016/j.genhosppsych.2021.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141345/
https://www.ncbi.nlm.nih.gov/pubmed/34045093
http://dx.doi.org/10.1016/j.genhosppsych.2021.05.005

Ejemplares similares